Karakteristik Komplikasi Luaran Janin dan Ibu Hamil yang Menderita Early Onset Preeclampsia (EOPE) dan Late Onset Preeclampsia (LOPE) yang Diterminasi di RSUD Raden Mattaher Jambi
DOI:
https://doi.org/10.62383/quwell.v2i2.2054Keywords:
Maternal Complications, Fetal Complications, Mother's OutcomeAbstract
Preeclampsia is a condition of hypertension occurring after 20 weeks of gestation, accompanied by organ dysfunction and proteinuria. Preeclampsia is classified into Early Onset Preeclampsia (EOPE), which occurs before 34 weeks of gestation, and Late Onset Preeclampsia (LOPE), which occurs after 34 weeks of gestation. EOPE carries a higher risk of maternal and fetal complications compared to LOPE. This research aims to analyze the complications in mothers and fetuses with EOPE and LOPE that were terminated at RSUD Raden Mattaher Jambi between 2020 and 2022. This descriptive research was conducted in the Medical Records Department of RSUD Raden Mattaher, Jambi, involving 82 patients who experienced both maternal and fetal complications with EOPE and LOPE that were terminated. Sampling was carried out using the total sampling technique based on inclusion and exclusion criteria. The results of this research showed that the prevalence of EOPE was 69.5%, while LOPE accounted for 30.5%. Maternal complications were more commonly found in EOPE cases, including eclampsia (42.1%), HELLP syndrome (36%), premature rupture of membranes (14%), placental abruption (14%), and maternal mortality (5.3%). Fetal complications in EOPE included Respiratory Distress Syndrome (RDS) (10.5%), prematurity (26.3%), low birth weight (29.8%), Intrauterine Growth Restriction (IUGR) (10.5%), and Intrauterine Fetal Death (IUFD) (1.8%). The perinatal mortality rate in EOPE was 7%, with asphyxia recorded in 12.3% of cases. EOPE is more frequently encountered than LOPE and is associated with more severe maternal and fetal complications. Early detection and management of EOPE are crucial to reducing complications and improving pregnancy outcomes.
References
Adikarya, I. P. G. D., & Wardana, G. A. (2022). Preeklampsia dengan gambaran berat sebagai faktor risiko kejadian asfiksia neonatorum. Intisari Sains Medis, 13(3), 618–624. https://doi.org/10.15562/ism.v13i3.1525
Akbar, M. I. A., Kinanti, H., Ernawati, E. E., & Lestari, P. (2021). Maternal and perinatal outcomes of early-onset and late-onset preeclampsia at a tertiary center hospital. Journal of South Asian Federation of Obstetrics and Gynaecology, 13(5), 338–342. https://doi.org/10.5005/JP-JOURNALS-10006-1915
Annafi, M. I., Jumsa, M. R., & Budyono, C. (2022). Gambaran preeklampsia berat dengan komplikasi di Rumah Sakit Umum Daerah Provinsi Nusa Tenggara Barat periode Januari 2018 sampai Desember 2019. Lombok Medical Journal, 1(1), 17–22. https://doi.org/10.29303/lmj.v1i1.534
Cunningham, F. (2018). Williams obstetric (R. Setia, Ed.; 25th ed.).
D’Souza, V., Rani, A., Patil, V., Pisal, H., Randhir, K., Mehendale, S., Wagh, G.,
Gupte, S., & Joshi, S. (2016). Increased oxidative stress from early pregnancy in women who develop preeclampsia. Clinical and Experimental Hypertension, 38(2), 225–232. https://doi.org/10.3109/10641963.2015.1081226
Dinas Kesehatan Provinsi Jambi. (2019). Profil kesehatan Jambi. Dk, 53(9), 1689–1699.
El-Sayed, Y. Y., Borders, A. E. B., & Gyamfi-Bannerman, C. (2017). Antenatal corticosteroid therapy for fetal maturation. Obstetrics and Gynecology, 130(2), E102–E109. https://doi.org/10.1097/AOG.0000000000002237
Firmansyah, F., Harahap, H., & Juniarti, A. K. (2022). Studi literature: Gambaran determinan kematian maternal. Electronic Journal Scientific of Environmental Health and Disease, 3(2), 154–159. https://doi.org/10.22437/esehad.v3i2.27767
Hartati, S., Herman, R. B., & Amir, D. (2015). Perbedaan kadar plasma pada penderita preeklampsia dengan kehamilan normotensif. Jurnal Kesehatan Andalas, 4(3), 822–826.
Herlambang, H., Enis, R. N., Octavia, E., & Kusdiyah, E. (2024). Profile of pregnant women with hypertension: A cross sectional study in Jambi City. Jambi Medical Journal, 12(1). https://doi.org/10.22437/jmj.v12i1.30958
Herlambang, H., Shafira, N. N. A., Maharani, C., Enis, R. N., Tarawifa, S., Puspasari, A., Kusdiyah, E., & Fitri, A. D. (2022). Skrining kadar vitamin D ibu hamil di wilayah kerja Puskesmas Tahtul Yaman Kota Jambi. Medical Dedication (Medic): Jurnal Pengabdian Kepada Masyarakat FKIK UNJA, 5(2), 440–444. https://doi.org/10.22437/medicaldedication.v5i2.21329
Herlambang, H., Tarawifa, S., Enis, R. N., Fitri, A. D., & Syauqi, A. (2021). Profil luaran maternal dan neonatal serta identifikasi ekspresi gen Sflt-1 pada pasien preeklampsia di Kota Jambi. PREPOTIF: Jurnal Kesehatan Masyarakat, 5(2), 1327–1335. https://doi.org/10.31004/prepotif.v5i2.2532
Izza, N., Kusdiyah, E., & Maharani, C. (2022). Gambaran karakteristik dan faktor risiko preeklampsia di Puskesmas Kota Jambi tahun 2017–2021. Journal of Medical Studies, 2(2), 38–60.
Kementerian Kesehatan Republik Indonesia. (2022). Profil kesehatan Indonesia 2021. https://pusdatin.kemkes.go.id
Mabula-Bwalya, C. M., et al. (2022). Association of mid-trimester maternal angiogenic biomarkers with small-for-gestational-age infants in an urban Zambian cohort: A nested case-control study. International Journal of Gynecology and Obstetrics, 157(3), 604–612. https://doi.org/10.1002/ijgo.13860
Maharani, C., Herlambang, H., Syauqy, A., Puspasari, A., Harahap, H., & Marlina, B. (2022). Hubungan ekspresi 8OH2DG sebagai penanda stres oksidatif kerusakan DNA dengan kejadian preeklampsia dan luaran neonatal. Jambi Medical Journal (JMJ), 10(4), 476–484.
Manurung, E., Ernawati, E., & Sampurna, M. (2025). Luaran maternal dan neonatal pada kasus solusio plasenta: Studi deskriptif di RSUD dr. Soetomo, Surabaya, Indonesia, tahun 2017–2024. Syntax Literate: Jurnal Ilmiah Indonesia, 10, 1436–1452. https://doi.org/10.36418/syntax-literate.v10i2.56781
Mecacci, F., et al. (2021). Fetal growth restriction: Does an integrated maternal hemodynamic-placental model fit better? Reproductive Sciences, 28(9), 2422–2435. https://doi.org/10.1007/s43032-020-00393-2
Muzalfah, R., Santik, Y. D. P., & Wahyuningsih, A. S. (2018). Kejadian preeklampsia pada ibu bersalin. HIGEIA (Journal of Public Health Research and Development), 2(3), 417–428.
Najmieh, S., et al. (2022). Maternal mortality in early and late onset preeclampsia: A retrospective cohort study. Journal of Obstetrics and Gynecology Research, 48(5), 1234–1240. https://doi.org/10.1111/jog.14689
Nofrienis, R., et al. (2021). Gambaran neutrophil lymphocyte ratio (NLR) pada early onset preeclampsia (EOP) dan late onset preeclampsia (LOP). Jambi Medical Journal, 9(3), 305–310.
Nuraini, L. A. P. (2017). Gambaran faktor penyebab intrauterine growth restriction (IUGR) di Rumah Sakit Khusus Ibu dan Anak Sadewa Sleman [Skripsi, Universitas tidak disebutkan].
Oltean, I., et al. (2022). The association of placental abruption and pediatric neurological outcome: A systematic review and meta analysis. Journal of Clinical Medicine, 12(1), 1–25.
Pinheiro, C. C., et al. (2014). The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia. Prenatal Diagnosis, 34(11), 1084–1092. https://doi.org/10.1002/pd.4432
Retno, W., Wittiarika, I. D., & Akbar, M. A. (2021). Hubungan antara awitan preeklampsia berat dengan komplikasi perinatal di Rumkital Dr. Ramelan Surabaya. Indonesian Midwifery and Health Sciences Journal, 5(2), 139–151. https://doi.org/10.20473/imhsj.v5i2.2021.139-151
Sibai, B. M., & Barton, J. R. (2007). Expectant management of severe preeclampsia remote from term: Patient selection, treatment, and delivery indications. American Journal of Obstetrics and Gynecology, 196(6), 514.e1–514.e9. https://doi.org/10.1016/j.ajog.2007.02.021
Sugara, L., et al. (2024). Jurnal Kesehatan dan Ilmu Kedokteran (JUKIK), 6(1), 8–24.
Sulistyowati, S. (2017). Early and late onset preeclampsia: What did really matter? Journal of Gynecology and Women's Health, 5(4), 7–9. https://doi.org/10.19080/jgwh.2017.05.555670
Sulistyowati, S., Soetrisno, S., Respati, S. H., & Wiyono, B. E. (2015). Faktor angiogenik soluble Fms-like tyrosine kinase-1 dan vascular endothelial growth factor pada ibu hamil 8–20 minggu dengan risiko preeklampsia. Jurnal Kesehatan Reproduksi, 2(1), 53–59. https://doi.org/10.22146/jkr.7129
Surya, R., & Pudyastuti, S. (2019). Persalinan preterm. Cermin Dunia Kedokteran, 46(1), 28–32.
Susanti. (2018). Perbandingan kejadian preeklampsia di rumah sakit daerah pantai dan pegunungan di Jawa Barat. Journal of Borneo Holistic Health, 1(1), 62–72.
Tranquilli, A. L. (2014). Early and late-onset pre-eclampsia. Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health, 4(3), 241–245. https://doi.org/10.1016/j.preghy.2014.04.007
Wojtowicz, A., et al. (2019). Early-and late-onset preeclampsia: A comprehensive cohort study of laboratory and clinical findings according to the new ISHHP criteria. International Journal of Hypertension, 2019.
Wulandari, E. S., Ernawati, E., & Nuswantoro, D. (2021). Risk factors of preeclampsia with severe features and its complications. Indonesian Midwifery and Health Sciences Journal, 5(1), 29–37. https://doi.org/10.20473/imhsj.v5i1.2021.29-37
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Quantum Wellness : Jurnal Ilmu Kesehatan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
